We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mylan Launches Its Generic Version of Bristol-Myers’ Paraplatin
Mylan Launches Its Generic Version of Bristol-Myers’ Paraplatin
Generic-maker Mylan has launched a version of Bristol-Myers Squibb’s advanced ovarian carcinoma drug Paraplatin Injection in 50 mg/5 ml multidose vials.